Theraworx Protect
Commercial- Indications
- Healthcare-associated infections, Immune health
Company intelligence / Profile preview
Prior to its bankruptcy in mid–2021, Avadim Health commercialized several over-the-counter topical healthcare products under the Theraworx brand for muscle cramps/spasms relief and infection prevention. No recent clinical trial results or new product launches have been reported since the company’s assets were sold as part of its liquidation process.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avadim Health.